Skip to main content

Advertisement

SpringerLink
Log in

Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas

  • Clinical-patient studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Most meningiomas are benign tumours of arachnoidal origin, although a small number have high proliferative rates and invasive properties which complicate complete surgical resection and are associated with increased recurrence rates. Few prognostic indicators exist for meningiomas and further research is necessary to identify factors that influence tumour invasion, oedema and recurrence. Paraffin sections from 25 intracranial meningiomas were analysed for expression of the proteins vascular endothelial growth factor (VEGF), VEGF receptors Flt1 and Flk1, E-cadherin, metalloproteinases 2 and 9 (MMP2, MMP9), CD44, receptor for hyaluronic acid-mediated motility (RHAMM), hyaluronic acid (HA), CD45, cyclooxygenase 2 (COX2), brain fatty acid binding protein (BFABP), Ki67, and proliferating cell nuclear antigen (PCNA). Correlations among protein expression were found for several markers of proliferation (Ki67, PCNA, MI) and microvessel density (MVD). COX2 expression increased with increasing with tumour grade and correlated with Ki67, PCNA, MI, MVD, and BFABP. BFABP expression also correlated with Ki67 and PCNA expression. Relationships were also identified among angiogenic factors (VEGF, Flt1, Flk1) and proliferation markers. Oedema was found to correlate with MMP9 expression and MMP9 also correlated with proliferation markers. No correlations were found for MMP2, E-cadherin, or CD44 in meningiomas. In conclusion Ki67, PCNA, MI, MVD, BFABP, and COX2 were significantly correlated with meningioma tumour grade and with each other. These findings, by correlating both intracellular fatty acid transport and eicosanoid metabolism with tumour proliferation, as determined by Ki67 labelling and mitotic index, suggest fatty acids are involved in the progression of meningiomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD (1993) Epidemiology of intracranial meningioma. Cancer 72(3):639–648

    Article  PubMed  Google Scholar 

  2. Louis DN, Scheithauer BW, Budka H, Von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of the tumors of the nervous system: World Health Organization classification of tumours. IARC Press, Lyon, pp 176–184

    Google Scholar 

  3. Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054

    Article  PubMed  CAS  Google Scholar 

  4. Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M (2003) Multiple meningiomas: investigating the molecular basis of sporadic and familial forms. Int J Cancer 103(4):483–488

    Article  PubMed  CAS  Google Scholar 

  5. Lusis E, Gutmann DH (2004) Meningioma: an update. Curr Opin Neurol 17(6):687–692

    Article  PubMed  Google Scholar 

  6. Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH (2000) Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 59(10):872–879

    PubMed  CAS  Google Scholar 

  7. Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19(5):E9

    Article  PubMed  Google Scholar 

  8. Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60(6):628–636

    PubMed  CAS  Google Scholar 

  9. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (2000) The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum Mol Genet 9(11):1567–1574

    Article  PubMed  Google Scholar 

  10. Murakami M, Hashimoto N, Takahashi Y, Hosokawa Y, Inazawa J, Mineura K (2003) A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression. Cancer Genet Cytogenet 140(2):99–106

    Article  PubMed  CAS  Google Scholar 

  11. Korshunov A, Cherekaev V, Bekyashev A, Sycheva R (2007) Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region. J Neurooncol 81:131–137

    Article  PubMed  CAS  Google Scholar 

  12. Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D (2002) Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 97(5):1078–1082

    PubMed  Google Scholar 

  13. Dweik A, Maheut-Lourmiere J, Lioret E, Jan M (1995) Radiation-induced meningioma. Childs Nerv Syst 11(11):661–663

    Article  PubMed  CAS  Google Scholar 

  14. Konstantinidou AE, Korkolopoulou P, Mahera H, Kotsiakis X, Hranioti S, Eftychiadis C, Patsouris E (2003) Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 43(3):280–290

    Article  PubMed  CAS  Google Scholar 

  15. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86(1):113–120

    PubMed  CAS  Google Scholar 

  16. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70(2):183–202

    Article  PubMed  Google Scholar 

  17. Verhagen A, Go KG, Visser GM, Blankenstein MA, Vaalburg W (1995) The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas. Br J Neurosurg 9(1):47–50

    Article  PubMed  CAS  Google Scholar 

  18. Zhao X, Teng LZ, Wang ZG, Xin T, Wei SC (2007) Expression and significance of glucocorticoid receptor alpha in meningiomas. J Clin Neurosci 14(4):359–363

    Article  PubMed  CAS  Google Scholar 

  19. Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. Lancet 363(9420):1535–1543

    Article  PubMed  Google Scholar 

  20. Domingo Z, Rowe G, Blamire AM, Cadoux-Hudson TA (1998) Role of ischaemia in the genesis of oedema surrounding meningiomas assessed using magnetic resonance imaging and spectroscopy. Br J Neurosurg 12(5):414–418

    Article  PubMed  CAS  Google Scholar 

  21. Pistolesi S, Fontanini G, Camacci T, De Ieso K, Boldrini L, Lupi G, Padolecchia R, Pingitore R, Parenti G (2002) Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J Neurooncol 60(2):159–164

    Article  PubMed  CAS  Google Scholar 

  22. Yoshioka H, Hama S, Taniguchi E, Sugiyama K, Arita K, Kurisu K (1999) Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer 85(4):936–944

    Article  PubMed  CAS  Google Scholar 

  23. Lieu AS, Howng SL (2000) Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res 38(1):45–52

    Article  PubMed  CAS  Google Scholar 

  24. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatr 20(1):22–39

    PubMed  CAS  Google Scholar 

  25. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62(1):18–24

    PubMed  CAS  Google Scholar 

  26. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J (1992) Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31(1):2–12

    Article  PubMed  CAS  Google Scholar 

  27. Palma L, Celli P, Franco C, Cervoni L, Cantore G (1997) Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86(5):793–800

    Article  PubMed  CAS  Google Scholar 

  28. Dietemann JL, Heldt N, Burguet JL, Medjek L, Maitrot D, Wackenheim A (1982) CT findings in malignant meningiomas. Neuroradiology 23(4):207–209

    Article  PubMed  CAS  Google Scholar 

  29. Ide M, Jimbo M, Kubo O, Yamamoto M, Imanaga H (1992) Peritumoral brain edema associated with meningioma histological study of the tumor margin and surrounding brain. Neurol Med Chir 32(2):65–71

    Article  CAS  Google Scholar 

  30. Mattei TA, Mattei JA, Ramina R, Aguiar PH, Plese JP, Marino R Jr (2005) Edema and malignancy in meningiomas. Clinics 60(3):201–206

    Article  PubMed  Google Scholar 

  31. Pistolesi S, Boldrini L, Gisfredi S, de Ieso K, Camacci T, Caniglia M, Lupi G, Leocata P, Basolo F, Pingitore R, Parenti G, Fontanni G (2004) Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118–125

    Article  PubMed  CAS  Google Scholar 

  32. Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R (1999) Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 98:240–244

    Article  PubMed  CAS  Google Scholar 

  33. Nathoo N, Barnett GH, Golubic M (2004) The eicosanoid cascade: possible role in gliomas and meningiomas. J Clin Pathol 57(1):6–13

    Article  PubMed  CAS  Google Scholar 

  34. Lin CCD, Kenyon L, Hyslop T, Hammond E, Andrews DW, Curran WJ, Dicker AP (2003) Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 26(4 Suppl 2):S98–S102

    PubMed  Google Scholar 

  35. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103(3):508–517

    PubMed  CAS  Google Scholar 

  36. Chmurzynska A (2006) The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 47(1):39–48

    PubMed  Google Scholar 

  37. Liang Y, Bollen AW, Aldape KD, Gupta N (2006) Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. BMC Cancer 6:97

    Article  PubMed  CAS  Google Scholar 

  38. Denizot Y, de Armas R, Caire F, Pommepuy I, Truffinet V, Labrousse F (2006) Platelet-activating factor and human meningiomas. Neuropathol Appl Neurobiol 32:674–678

    Article  PubMed  CAS  Google Scholar 

  39. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109:588–597

    Article  PubMed  CAS  Google Scholar 

  40. McKeever PE (1998) Insights into brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J Histochem Cytochem 46(5):585–594

    PubMed  CAS  Google Scholar 

  41. Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37–44

    Article  CAS  Google Scholar 

  42. Quiñones-Hinojosa A, Sanai N, Smith JS, McDermott MW (2005) Techniques to assess the proliferative potential of brain tumors. J Neurooncol 74:19–30

    Article  PubMed  Google Scholar 

  43. Kim YJ, Ketter R, Henn W, Zang KD, Steudel WI, Feiden W (2006) Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 449:529–538

    Article  PubMed  CAS  Google Scholar 

  44. Otsuka S, Tamiya T, Ono Y, Michiue H, Kurozumi K, Daido S, Kambara H, Date I, Ohmoto T (2004) The relationship between peritumoural brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 70:349–357

    Article  PubMed  Google Scholar 

  45. Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, Jung HW (2002) Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol 60:235–245

    Article  PubMed  Google Scholar 

  46. Seto T, Higashiyama M, Funai H, Imamura F, Uematsu K, Seki N, Eguchi K, Yamanaka T, Ichinose Y (2006) Prognostic value of expression of vascular endothelial growth factor and its Flt-1 and Kdr receptors in stage I non-small-cell lung cancer. Lung Cancer 53:91–96

    Article  PubMed  Google Scholar 

  47. Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469–478

    PubMed  CAS  Google Scholar 

  48. Kiliç T, Bayri Y, Ozduman K, Acar M, Diren S, Kurtkaya O, Ekinci G, Bugra K, Sav A, Ozek MM, Pamir MN (2002) Tenascin in meningioma: expression is correlated with anaplasis, vascular endothelial growth factor expression and peritumoral edema but not with tumor border shape. Neurosurgery 51:183–193

    Article  PubMed  Google Scholar 

  49. Tchilian EZ, Beverly PCL (2006) Altered CD45 expression and disease. Trends Immunol 27(3):146–153

    Article  PubMed  CAS  Google Scholar 

  50. Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao S (2004) Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. J Neurooncol 66:29–37

    Article  PubMed  Google Scholar 

  51. Von Randow AJU, Schindler S, Tews DS (2006) Expression of extracellular matrix degrading proteins in classic, atypical and anaplastic meningiomas. Pathol Res Pract 202:365–372

    Article  CAS  Google Scholar 

  52. Okuducu AF, Zils U, Michaelis SAM, Michaelides S, von Deimling A (2006) Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology 48:836–845

    Article  PubMed  CAS  Google Scholar 

  53. Kiran MS, Kumar VBS, Viji RI, Sudhakaran PR (2006) Temporal relationship between MMP production and angiogenic process in HUVECS. Cell Biol Int 30:704–713

    Article  PubMed  CAS  Google Scholar 

  54. Rosell A, Ortega-Aznar A, Alvarez-sabin J, Fernandez-Cadenas I, Ribo M, Molina CA, Lo EH, Montaner J (2006) Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37:1399–1406

    Article  PubMed  CAS  Google Scholar 

  55. Tejima E, Zhao BQ, Tsuji K, Rosell A, van Leyen K, Gonzalez RG, Montaner J, Wang X, Lo EH (2007) Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J Cereb Blood Flow Metab 27(3):460–468

    Article  PubMed  CAS  Google Scholar 

  56. Schwechheeimer K, Zhou L, Birchmeier W (1998) E-cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch 432:163–167

    Article  Google Scholar 

  57. Shimada S, Ishizawa K, Hirose T (2005) Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Pathol Int 55:1–7

    Article  PubMed  CAS  Google Scholar 

  58. Lusis EA, Chicoine MR, Perry A (2005) High throughput screening of meningioma biomarkers using tissue microarray. J Neurooncol 73:219–223

    Article  PubMed  CAS  Google Scholar 

  59. Brunner EC, Romeike BFM, Jung M, Comtesse N, Meese E (2006) Altered expression of beta-catenin/E-cadherin in meningiomas. Histopathology 49:178–187

    Article  PubMed  CAS  Google Scholar 

  60. Turley EA, Noble PW, Bourguignon LYW (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277(7):4589–4592

    Article  PubMed  CAS  Google Scholar 

  61. Yang CW, Su JY, Tsou AP, Chau GY, Liu HL, Chen CH, Chien CY, Chou CK (2005) Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example. Biochem Biophys Res Commun 330:489–497

    Article  PubMed  CAS  Google Scholar 

  62. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S (2007) Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26(1):58–68

    Article  PubMed  CAS  Google Scholar 

  63. Suzuki SO, Iwaki T, Kitamoto T, Mizoguchi M, Fukui M, Tateishi J (1996) Differential expression of CD44 variants among meningioma subtypes. J Clin Pathol Mol Pathol 49:M140–M146

    Google Scholar 

  64. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046–1069

    Article  PubMed  CAS  Google Scholar 

  65. Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, Hiraiwa Y, Senga T, Sohara Y, Matsuda S, Hamaguchi M (2002) Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 62:3962–3965

    PubMed  CAS  Google Scholar 

  66. Gotte M, Yip GW (2006) Heparanase, hyaluronan and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66(21):10233–10237

    Article  PubMed  Google Scholar 

  67. Tolg C, Hamilton SR, Nakrieko KA, Kooshesh F, Walton P, McCarthy JB, Bissell MJ, Turley EA (2006) Rhamm–/– fibroblasts are defective in CD44-mediated ERK1, 2 motogenic signaling, leading to defective skin wound repair. J Cell Biol 175(6):1017–1028

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Santa Casa Hospital, São Paulo, Brazil

    Alexandros Theodoros Panagopoulos & José Carlos Esteves Veiga

  2. Department of Pathology, Santa Casa Hospital, São Paulo, Brazil

    Carmen Lucia Penteado Lancellotti

  3. Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil

    Paulo Henrique Pires de Aguiar

  4. Department of Cell and Developmental Biology, University of São Paulo, São Paulo, SP, CEP 05508-900, Brazil

    Alison Colquhoun

Authors
  1. Alexandros Theodoros Panagopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carmen Lucia Penteado Lancellotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Carlos Esteves Veiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paulo Henrique Pires de Aguiar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alison Colquhoun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alison Colquhoun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panagopoulos, A.T., Lancellotti, C.L.P., Veiga, J.C.E. et al. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas. J Neurooncol 89, 73–87 (2008). https://doi.org/10.1007/s11060-008-9588-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9588-3

Keywords

Search

Navigation